The insulin receptor is a membrane macromolecule whose expression on t
he cell surface is essential for cell sensitivity to insulin. Current
knowledge on the regulation of expression of the insulin receptor and
its gene in human and animal cells is presented. Although ubiquitously
distributed, the insulin receptor and its messenger RNA (mRNA) are ma
inly expressed in metabolically active cells such as hepatocytes and a
dipocytes. Two receptor isoforms, generated by alternative splicing of
exon 11, have been identified. Isoform B (exon 11+) predominates in l
iver and adipocytes, and isoform A (exon 11-) in brain, spleen and leu
kocytes. In vivo and in several cell models, the expression of the ins
ulin receptor and/or its mRNA is under positive regulation by glucocor
ticoid hormones and negative regulation by insulin. Glucocorticoid hor
mones stimulate receptor gene transcription and receptor protein synth
esis. Insulin stimulates receptor protein degradation and, in certain
cell types, decreases receptor mRNA level. Vanadate (an insulinomimeti
c agent) corrects, in vivo, the hyperexpression of the liver receptor
observed in experimental insulinopenic diabetes, but its effects on re
ceptor expression in vitro are complex and vary with the cell type. In
vivo the insulin receptor and/or its mRNA are expressed early in feta
l development with a high level, in liver, of isoform A. Maximal expre
ssion is reached at the end of gestation and then decreases after birt
h. In several cell models, receptor protein and/or mRNA expression is
affected by cell growth and/or differentiation. Several cis- and trans
-acting factors regulating the expression of the human insulin recepto
r gene and its response to glucocorticoid hormones have been identifie
d.